Discounted Cash Flow (DCF) Analysis Levered

KORU Medical Systems, Inc. (KRMD)

$2.11

-0.01 (-0.47%)
All numbers are in Millions, Currency in USD

Free Cash Flow

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 17.3523.1624.1823.4927.9031.6535.9040.7346.2052.41
Revenue (%)
Operating Cash Flow 1.480.32-0.74-4.32-5.40-1.96-2.22-2.52-2.86-3.24
Operating Cash Flow (%)
Capital Expenditure -0.48-0.43-1.06-0.38-2.80-1.31-1.48-1.68-1.91-2.16
Capital Expenditure (%)
Free Cash Flow 1-0.10-1.80-4.69-8.21-3.26-3.70-4.20-4.76-5.41

Weighted Average Cost Of Capital

Share price $ 2.11
Beta 0.518
Diluted Shares Outstanding 45
Cost of Debt
Tax Rate 18.87
After-tax Cost of Debt -%
Risk-Free Rate
Market Risk Premium
Cost of Equity 6.604
Total Debt 4.93
Total Equity 94.95
Total Capital 99.88
Debt Weighting 4.93
Equity Weighting 95.07
Wacc

Build Up Free Cash Flow

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 17.3523.1624.1823.4927.9031.6535.9040.7346.2052.41
Operating Cash Flow 1.480.32-0.74-4.32-5.40-1.96-2.22-2.52-2.86-3.24
Capital Expenditure -0.48-0.43-1.06-0.38-2.80-1.31-1.48-1.68-1.91-2.16
Free Cash Flow 1-0.10-1.80-4.69-8.21-3.26-3.70-4.20-4.76-5.41
WACC
PV LFCF -----
SUM PV LFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) -5.51
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -12.48
Equity Value -
Shares Outstanding 45
Equity Value Per Share -